Tolerability of Dalpiciclib vs. Abemaciclib/Ribociclib in Early HR+/HER2- Breast Cancer
Clinical trial NCT07706933 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07706933
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-06-30
- Enrollment
- 456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.